학술논문
A Phase 1 First-in-Human Single-Ascending-Dose Trial With ESB1609, a Selective Agonist to the Sphingosine-1-Phosphate Receptor 5
Document Type
Article
Author
Source
In: Clinical Pharmacology in Drug Development . (Clinical Pharmacology in Drug Development, June 2023, 12(6):625-638)
Subject
Language
English
ISSN
21607648
2160763X
2160763X